Key Drug-Pricing Legislation to Cap Insulin Costs Faces Hurdles in Congress

Major drug-pricing legislation to cap the cost of insulin is in danger of slipping to the fall, where it risks getting lost amid fights over appropriations bills, abortion and a potential government shutdown.

The legislation is a priority for Democrats, and Majority Leader Chuck Schumer (D-N.Y.) said earlier this month that he was hoping to combine the insulin bill and legislation reforming the pharmacy benefit manager (PBM) industry into a package that could get bipartisan support and a vote before the end of summer.

In a press conference earlier this month, he said passing an insulin bill was a “very, very high priority.”

Read the source article at The Hill